Clinical Trials Directory

Trials / Completed

CompletedNCT01302210

Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities

Detection, Education, Research and Decolonization Without Isolation in Long-term Care to Control(DERAIL)MRSA

Status
Completed
Phase
Study type
Observational
Enrollment
22,302 (actual)
Sponsor
Endeavor Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our hypothesis for the DERAIL MRSA program is that one can safely remove the colonization risk from nearly all residents (patients) in a way that does not interfere with the desired life-style for persons in these facilities and thereby reduce the risk of infection and lower the cost of care by avoiding preventable disease.

Detailed description

The primary endpoint will be measuring the reduction in MRSA colonization prevalence (percentage rate) in the intervention arm as compared to the control arm. One secondary endpoint is to compare the rate of MRSA disease (number of infections per 1,000 patients and 10,000 patient days) in the intervention and control arms. The other secondary endpoint is to determine the cost of MRSA screening and decolonization and compare it to the cost of MRSA disease treatment (both medication cost and the expense of any needed hospitalization for therapy of MRSA infection therapy) in the control arm. Achieving our primary goal of MRSA control will also demonstrate two secondary goals wthe investigators aim to achieve: one being that a scientific, planned approach to the issue of specific healthcare-associated infection in LTCFs can resolve these problems and the other that a partnership between acute and long-term care (e.g., ongoing relationship spanning at least 5 years) is beneficial in dealing with patient safety and quality practices across the United Sates Healthcare continuum.

Conditions

Interventions

TypeNameDescription
DRUGDecolonization5 day regimen of mupirocin calcium 2% twice daily to the nares and any open wound plus bath or shower with 4% chlorhexidine used as a liquid soap

Timeline

Start date
2010-10-01
Primary completion
2013-12-01
Completion
2014-11-01
First posted
2011-02-24
Last updated
2019-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01302210. Inclusion in this directory is not an endorsement.